Durect Corp (DRRX)
0.9159
+0.03
(+3.67%)
USD |
NASDAQ |
Apr 25, 16:00
0.9127
0.00 (0.00%)
After-Hours: 20:00
Durect Cash from Financing (TTM): 20.50M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 20.50M |
September 30, 2023 | 21.75M |
June 30, 2023 | 10.02M |
March 31, 2023 | 10.08M |
December 31, 2022 | 0.083M |
September 30, 2022 | 0.21M |
June 30, 2022 | 0.068M |
March 31, 2022 | -0.508M |
December 31, 2021 | 50.53M |
September 30, 2021 | 50.83M |
June 30, 2021 | 58.05M |
March 31, 2021 | 65.95M |
December 31, 2020 | 15.66M |
September 30, 2020 | 19.07M |
June 30, 2020 | 12.21M |
March 31, 2020 | 20.21M |
December 31, 2019 | 19.50M |
September 30, 2019 | 14.78M |
June 30, 2019 | 14.54M |
March 31, 2019 | 3.436M |
December 31, 2018 | 17.48M |
September 30, 2018 | 20.88M |
June 30, 2018 | 25.94M |
March 31, 2018 | 25.97M |
December 31, 2017 | 12.62M |
Date | Value |
---|---|
September 30, 2017 | 13.67M |
June 30, 2017 | 9.549M |
March 31, 2017 | 22.51M |
December 31, 2016 | 23.08M |
September 30, 2016 | 22.33M |
June 30, 2016 | 21.28M |
March 31, 2016 | 16.29M |
December 31, 2015 | 15.20M |
September 30, 2015 | 12.45M |
June 30, 2015 | 17.28M |
March 31, 2015 | 24.93M |
December 31, 2014 | 24.79M |
September 30, 2014 | 35.54M |
June 30, 2014 | 30.88M |
March 31, 2014 | 11.07M |
December 31, 2013 | 10.98M |
September 30, 2013 | 11.88M |
June 30, 2013 | 11.88M |
March 31, 2013 | 11.84M |
December 31, 2012 | 11.84M |
September 30, 2012 | 0.239M |
June 30, 2012 | 0.176M |
March 31, 2012 | 0.384M |
December 31, 2011 | 1.111M |
September 30, 2011 | 1.276M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.508M
Minimum
Mar 2022
65.95M
Maximum
Mar 2021
21.24M
Average
15.66M
Median
Dec 2020
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |